Man Group PLC Silverback Therapeutics, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	N/A	4,169 Added 26.6%	19,839 $0
Q4 2022 Feb 14, 2023	BUY	$0.0 - $6.07 $0 - $95,116	15,670 New	15,670 $0
Q4 2021 Feb 14, 2022	SELL	$6.03 - $11.67 $139,371 - $269,728	-23,113 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.98 - $35.22 $96,506 - $340,577	9,670 Added 71.93%	23,113 $231,000
Q2 2021 Aug 16, 2021	BUY	$24.71 - $44.28 $332,176 - $595,256	13,443 New	13,443 $415,000

163

62.7M

872K

589K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.